CAT vs CGEM · P/E 48, rev $20.54B vs $830.3M cap
Caterpillar Inc (CAT) versus Cullinan Oncology LLC (CGEM) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. CGEM currently screens at market cap $830.3M.
Not investment advice. Open the CAT and CGEM stock pages for the full models.
Not investment advice.